caspase 3 inhibitors (Cytoclonal)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namecaspase 3 inhibitors (Cytoclonal)
Drug Alias Namecaspase 3 inhibitors (eXegenics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCaspase-3 inhibitors
TargetsCaspase-3
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOpko Health Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOpko Health Inc
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A